IBDX®
Inflammatory Bowel Disease (Diagnosis, Prognosis, Therapy Monitoring)
CommercialActive
Key Facts
Indication
Inflammatory Bowel Disease (Diagnosis, Prognosis, Therapy Monitoring)
Phase
Commercial
Status
Active
Company
About GlycoMinds
GlycoMinds is a private, commercial-stage diagnostics company headquartered in San Diego, California, focused on gastroenterology. Its core technology is a validated serum biomarker platform that powers the IBDX® test, used for diagnosing IBD subtypes (Crohn's Disease vs. Ulcerative Colitis), prognosticating disease course, and monitoring therapy response. The company targets a significant unmet need for non-invasive tools in the growing IBD market, positioning itself as a specialist with a clinically validated product. Its business model involves selling diagnostic reagents in the USA and kits internationally.
View full company profile